Reversion of left ventricle remodeling in spontaneously hypertensive rats by valsartan is associated with the inhibition of caspase-3, -8 and -9 activities

Abstract

Abstract. The development of hypertension is closely associated with cardiac hypertrophy and apoptosis, and caspase-3, -8 and -9 are key enzymes of apoptosis. The aim of the present study was to evaluate the effects of valsartan on left ventricle hypertrophy and myocardial apoptosis in spontaneously hypertensive rats (SHRs) and to explore the mechanisms for valsartan against apoptosis. A total of 15 SHRs (16 weeks old) were randomly divided into two groups. The SHRs in the valsartan (n=8) and SHR groups (n=7) were fed with valsartan and distilled water for 8 weeks, respectively. Wistar-Kyoto rats (n=8) were the control group. At the end of the experiments, blood pressure, parameters regarding hypertrophy, apoptosis and activities of caspase-3, -8 and -9 were measured. The results showed that valsartan significantly reduced systolic blood pressure and left ventricular hypertrophy, improved left ventricular remodeling, attenuated the myocardial damage and apoptosis, and decreased the activities of caspase-3, -8 and -9 in SHRs. In conclusion, valsartan is able to reverse hypertension-induced left ventricle remodeling, which is associated with, at least in part, its inhibitory effect on myocardial apoptosis in the death receptor-mediated extrinsic, as well as the mitochondrial-mediated intrinsic pathways.

Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway

“…Caspase-8 participates in cell apoptosis through forming a death-inducing signaling complex (25). The caspase protease family occupies the central role in the apoptosis process and participates directly in early initiation, signal transmission and late apoptotic effects (26). Caspase-8 is at the peak of the cascade reaction.…”

Effect of the Single-Pill Amlodipine/Valsartan Combination on Hypertrophy and Myocardial Deformation Characteristics in Middle-Aged Patients with Essential Arterial Hypertension

“…Еще в одной экспериментальной работе [26] [26][27][28] доказано, что АГ ассоциируется с апоптозом кардиомиоцитов, на фоне которого в последующем развивается фиброз миокарда и повышение его жесткости. Каспазы же играют ключевую роль в апоптозе и процессах воспаления, и, тем самым, являются их маркерами.…”

Clinical management of dilated cardiomyopathy: current knowledge and future perspectives

“…Experimental studies have demonstrated that LVRR is dictated by decreases in extracellular matrix gene expression and the decreased activities of caspase −3, −8 and −9, and the inhibition of myocardial apoptosis coupled with a significant increase in calcium handling proteins and adenylate cyclase gene expression. [19] Another important therapeutic option might be the correction of FMR. Hence, the introduction of novel device therapy, such as Mitraclip, could contribute to improve the outcomes of DCM patients.…”